![Astex Pharmaceuticals, Inc. logo](/news-release/logo/213737/0/213737.jpg?lastModified=12%2F09%2F2016%2023%3A12%3A02&size=2)
Astex Pharmaceuticals to Announce 2013 Second Quarter Financial Results on August 1st
29 juil. 2013 06h00 HE
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., July 29, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
![Astex Pharmaceuticals, Inc. logo](/news-release/logo/213737/0/213737.jpg?lastModified=12%2F09%2F2016%2023%3A12%3A02&size=2)
Astex Pharmaceuticals Announces First Data Showing Early Combination Treatment of HSP90 Inhibitor AT13387 With Targeted Agents Delays Emergence of Resistance in Preclinical Models
22 juil. 2013 06h00 HE
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., July 22, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
![Astex Pharmaceuticals, Inc. logo](/news-release/logo/213737/0/213737.jpg?lastModified=12%2F09%2F2016%2023%3A12%3A02&size=2)
Astex Pharmaceuticals Announces IND Candidate: ASTX727 a Potential Best-in-Class Oral Hypomethylator
08 juil. 2013 06h00 HE
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., July 8, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
![Astex Pharmaceuticals, Inc. logo](/news-release/logo/213737/0/213737.jpg?lastModified=12%2F09%2F2016%2023%3A12%3A02&size=2)
Astex Pharmaceuticals to Present at JMP Securities Healthcare Conference
03 juil. 2013 06h00 HE
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., July 3, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
![Astex Pharmaceuticals, Inc. logo](/news-release/logo/213737/0/213737.jpg?lastModified=12%2F09%2F2016%2023%3A12%3A02&size=2)
Astex Pharmaceuticals Announces Oral Presentation of SGI-110 Data at the Upcoming European Cancer Congress (ECCO-ESMO-ESTRO)
20 juin 2013 06h00 HE
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., June 20, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
![Astex Pharmaceuticals, Inc. logo](/news-release/logo/213737/0/213737.jpg?lastModified=12%2F09%2F2016%2023%3A12%3A02&size=2)
Astex Pharmaceuticals Announces Presentation of Updated Results of SGI-110-01 Study in Patients With Intermediate or High Risk Relapsed or Refractory Myelodysplastic Syndromes at the European Hematology Association
14 juin 2013 06h00 HE
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., June 14, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
![Astex Pharmaceuticals, Inc. logo](/news-release/logo/213737/0/213737.jpg?lastModified=12%2F09%2F2016%2023%3A12%3A02&size=2)
Astex Pharmaceuticals to Present at Jefferies Global Healthcare Conference
29 mai 2013 06h00 HE
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., May 29, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
![Astex Pharmaceuticals, Inc. logo](/news-release/logo/213737/0/213737.jpg?lastModified=12%2F09%2F2016%2023%3A12%3A02&size=2)
Astex Pharmaceuticals to Present at UBS Global Healthcare Conference
14 mai 2013 06h00 HE
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., May 14, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
![Astex Pharmaceuticals, Inc. logo](/news-release/logo/213737/0/213737.jpg?lastModified=12%2F09%2F2016%2023%3A12%3A02&size=2)
Astex Pharmaceuticals Reports 2013 First Quarter Financial Results
29 avr. 2013 16h00 HE
|
Astex Pharmaceuticals, Inc.
Data reported at AACR on several preclinical and clinical programs
Ends quarter with $137 million in cash & marketable securities
First quarter royalty revenue increases 7.3% to $22.1...
![Astex Pharmaceuticals, Inc. logo](/news-release/logo/213737/0/213737.jpg?lastModified=12%2F09%2F2016%2023%3A12%3A02&size=2)
Astex Pharmaceuticals to Present at Needham Healthcare Conference
23 avr. 2013 06h00 HE
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., April 23, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...